ExploreInterventionHuman fibrinogen and thrombin only product
Intervention

Human fibrinogen and thrombin only product

Also known as: Fibrinogen and MCP-1 levels as biomarkers for diabetes risk prediction Human fibrinogen and thrombin only product Product containing only human fibrinogen and thrombin (medicinal product)
3 findings 1 paper 3 related entities View in graph →

Related entities

conditions
outcomes
studys

Findings (27)

None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models
None
null

Neither fibrinogen nor MCP-1 showed any significant association with incident diabetes in any intervention group under any level of adjustment.

Effect: null; non-significant in all groups and all models

Size: non-significant in all groups and all models

Papers (1)